External collaborations Show filterHide filter All AllIndustrial partnersInternational alliances BEAM Alliance Launched in June 2015, the BEAM (Biotech companies from Europe innovating Anti-Microbial resistance research) Alliance is a… BioNTech In collaboration with BioNTech and the biopharmaceutical research institute Translational Oncology at the University of Mainz… CARB-X CARB-X (Combating Antibiotic Resistant Biopharmaceutical Accelerator) is a funding organisation for projects in the field of… Centre de Recherche en Santé de Nouna (CRSN) The "Centre de Recherche en Santé de Nouna" (CRSN) in Burkina Faso developed from a large public health research project… Centre de Recherches Médicales de Lambaréné (CERMEL) The "Centre de Recherches Médicales de Lambaréné" (CERMEL), Gabon, is one of the leading institutions for malaria research in… Coalition for Epidemic Preparedness Innovations (CEPI) The global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the… Coris BioConcept DZIF scientists from the Institute of Medical Microbiology, Immunology and Hygiene at the University of Cologne have… Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi), founded in 2003, develops new treatments for neglected diseases and… Global AMR R&D Hub The Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub for short, is an initiative of… HYpharm GmbH HYpharm GmbH and a DZIF-funded consortium are collaborating to manufacture and preclinically develop the phage lysine protein… Pagination < Zurück Current page 1 Seite 2 Seite 1 Seite 2 Next page ››
